A Clinical Study to Determine the Safety, Tolerability and Effect of RLS-0071 Doses When Given to Healthy Adults After Inhaling LPS
Clinical trial NCT05351671 · COMPLETED
Trial details
- NCT number
- NCT05351671
- Sponsor
- ReAlta Life Sciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-23
- Primary completion
- 2022-09-21
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.